Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
1.25 Fte (5)
Lobbyists with EP accreditation
1
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Foundation for Innovative New Diagnostics (FIND)
EU Transparency Register
158922541572-78 First registered on 01 Mar 2021
Goals / Remit
We are a global non-profit organization driving innovation in the development and delivery of diagnostics to combat major diseases affecting the world’s poorest populations.
Diagnostics often do not exist, are inaccessible, or cost too much. They remain under-resourced and overlooked, despite being pivotal for guiding the best treatment for individual patients; for preventing the spread of disease and antimicrobial resistance; and for enhancing surveillance for early disease detection and monitoring.
With priorities aligned to those of the global public health community, we turn complex diagnostic challenges into simple solutions through unique partnerships with the public, private and non-profit sectors.
FIND is a WHO Collaborating Centre for Laboratory Strengthening and Diagnostic Technology Evaluation.
Our work bridges R&D to access: we have deep technical and practical experience in the definition of needs, development of fit-for-purpose products...Main EU files targeted
EU legislative proposals or policies we will engage with and advocate will relate to global health, international development, research & development, scientific innovation, human rights & gender issues, and the role of the EU and its member states in all of the above, as well as its implications and interactions with low and middle income countries (LMICS).
Specifically, policy areas we will be involved with: the EU’s Global Approach on R&I, the new EU strategy with Africa and the EU communication on global health.
Specific EU mechanisms and entities we have been and will be interacting with and aiming to engage with and advocate with include the Joint Undertakings Partnerships (such as EDCTP3 and IHI), Innovative Medicines Initiative, HERA, the EU4HEALTH programme and Horizon Europe.
In 2021 we have also contributed to the Keeping the Promise initiative: https://www.keepingthepromisereport.org/Address
Head Office
Campus Biotech Chemin des Mines 9
Geneva 1202
SWITZERLANDEU Office
Campus Biotech Chemin des Mines 9
Geneva 1202
SWITZERLANDWebsite
-
People
Total lobbyists declared
5
Employment time Lobbyists 25% 5 Lobbyists (Full time equivalent)
1.25
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
1 accreditations were / are live (in bold) for the selected state of 06 May 2024
Name Start date End Date Willo BROCK 30 Jan 2024 29 Jan 2025 Complementary Information
We have 5 persons involved in EU-related policy, communications, advocacy, across our External Affairs Team.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
Partnerships are the core of our operating model. Our unique position, bridging the public and private sectors, allows us to bring a diverse set of stakeholders together to resolve technical, financial and logistical barriers to diagnostic innovation in low-resource settings.
Our many partners include public, government donors, philanthropic organizations, commercial companies, academic and research institutions, international public health organizations (including non-governmental organizations and foundations), health ministries and disease control programmes.
More information, including about our donors, is available here: https://www.finddx.org/partners-donors/
Furthermore, FIND is member of the Global Health Technologies Coalition, Malaria No More, the Swiss Alliance on Neglected Tropical Diseases (SANTD), the Swiss Malaria Group, the G20 Health and Development Partnership, and the Chagas Coalition.Member organisations
None declared
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
89,918,111€
Major funding types in closed year
EU funding, Public financing
Major contributions in closed year
Type Name Amount Contribution UK Foreign, Commonwealth & Development Office 4,502,143€ Contribution German Government 6,371,082€ Contribution Bill & Melinda Gates Foundation 5,420,617€ Contribution Unitaid 4,728,393€ Contribution UK Department of Health 2,176,670€ Contribution The Global Fund to Fight Aids, TB and Malaria 11,592,433€ Contribution Australian Aid 5,265,022€ Contribution Global Health Innovative Technology Fund 811,277€ Contribution Government of the Netherlands 1,905,410€ Contribution European and Developing Countries Clinical Trials Partnership 960,894€ Contribution Rockefeller Foundation 93,700€ Contribution Government of the Kingdom of Saudi Arabia 2,355,618€ Contribution Government of Canada 10,977,658€ Contribution Other contributions 3,201,393€ Contribution World Health Organization 56,220€ Contribution Swiss Development Cooperation 2,215,772€ Contribution Black Rock Foundation 4,685,000€ Contribution Helmsley Charitable Trust 1,048,857€ Contribution Brazil, FIOCRUZ 599,948€ Contribution End Fund 673,737€ Contribution Government of the United States 555,838€ Contribution Government of the Federal Republic of Germany 19,700,430€ Grant European and Developing Countries Clinical Trials Partnership 960,894€ Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
Health
Communication activities
Our public relations and communication activities will be related to any of the above-mentioned areas of work/expertise. Specifically, we will engage with areas including international cooperation and external relations with LMICs, global health, research and innovation and gender and human rights.
Other activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 22 Apr 2024 Location Brussels Subject Support of the European Framework Programme for health research and innovation Cabinet Cabinet of Commissioner Iliana Ivanova Attending - Nelly Bruno (Cabinet member)
- Iliana Ivanova (Commissioner)
Other Lobbyists